Kia et al., 2019 - Google Patents
Integration of eQTL and Parkinson's disease GWAS data implicates 11 disease genesKia et al., 2019
View PDF- Document ID
- 14989989289492873018
- Author
- Kia D
- Zhang D
- Guelfi S
- Manzoni C
- Hubbard L
- United Kingdom Brain Expression Consortium (UKBEC)
- International Parkinson’s Disease Genomics Consortium (IPDGC)
- Reynolds R
- Botía J
- Ryten M
- Ferrari R
- Lewis P
- Williams N
- Trabzuni D
- Hardy J
- Wood N
- Publication year
- Publication venue
- BioRxiv
External Links
Snippet
Substantial genome-wide association study (GWAS) work in Parkinson's disease (PD) has led to an increasing number of loci shown reliably and robustly to be associated with the increased risk of the disease. Prioritising causative genes and pathways from these studies …
- 206010061536 Parkinson's disease 0 title abstract description 72
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Broekema et al. | A practical view of fine-mapping and gene prioritization in the post-genome-wide association era | |
Wray et al. | Common disease is more complex than implied by the core gene omnigenic model | |
Bandres‐Ciga et al. | The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease | |
Zhou et al. | Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals | |
Unal Gulsuner et al. | Mitochondrial serine protease HTRA2 p. G399S in a kindred with essential tremor and Parkinson disease | |
Gazzellone et al. | Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variation | |
Arguello et al. | Genetic and cognitive windows into circuit mechanisms of psychiatric disease | |
Ni et al. | The GWAS risk genes for depression may be actively involved in Alzheimer’s disease | |
Xiao et al. | The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders | |
Xie et al. | Serotonin transporter 5‐HTTLPR genotype moderates the effects of childhood adversity on posttraumatic stress disorder risk: A replication study | |
Wade et al. | Genetic variants associated with disordered eating | |
Maestrini et al. | Identifying autism susceptibility genes | |
Nalls et al. | Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable risk | |
Shinozaki et al. | New developments in the genetics of bipolar disorder | |
Acosta et al. | ADGRL 3 (LPHN 3) variants are associated with a refined phenotype of ADHD in the MTA study | |
Wu et al. | RNA sequencing in post‐mortem human brains of neuropsychiatric disorders | |
CN106170561A (en) | The diagnosis of autism spectrum disorder and prediction | |
Subaran et al. | Novel variants in ZNF34 and other brain‐expressed transcription factors are shared among early‐onset MDD relatives | |
Alazami et al. | NECAP1 loss of function leads to a severe infantile epileptic encephalopathy | |
Amor | Investigating the child with intellectual disability | |
Kia et al. | Integration of eQTL and Parkinson’s disease GWAS data implicates 11 disease genes | |
Han et al. | Identification of key long non-coding RNAs in the pathology of Alzheimer’s disease and their functions based on genome-wide associations study, microarray, and RNA-seq data | |
Stepanov et al. | Replicative study of susceptibility to childhood-onset schizophrenia in Kazakhs | |
Arenella et al. | Autism spectrum disorder and brain volume link through a set of mTOR‐related genes | |
Houle et al. | Teneurin transmembrane protein 4 is not a cause for essential tremor in a Canadian population |